|
|
|
Volumn 16, Issue 11 Suppl 13, 2002, Pages 4-10
|
|
Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
INTERLEUKIN 2;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
MELANOMA;
METASTASIS;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS, PHASE III;
HUMANS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, SUBCUTANEOUS;
INTERFERON-ALPHA;
INTERLEUKIN-2;
KIDNEY NEOPLASMS;
MELANOMA;
|
|
EID: 0036833980
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (107)
|
|
References (38)
|
